Cannabis — Sep 28 – Oct 2, 2026 (Wk 40): Cannabis Sector Sees Mixed Performance Amid Regulatory Pause and Capacity Expansion

October 2, 2026 · · 7 min read
Weekly theme roundup · Sep 28 – Oct 2, 2026
Covering the 12 Cannabis stocks in our database — browse every Cannabis name →

TL;DR — The cannabis sector experienced varied stock movements this week, influenced by a reported pause in federal rescheduling efforts and individual company developments. While some companies expanded production or saw stock gains, others faced selling pressure, highlighting the ongoing impact of regulatory uncertainty and market dynamics on the industry.

Median price / model value
1.15×
the typical stock trades above our model value · 12 stocks
Insider tape (CMP-filtered)
0 buys
open-market, routine & 10b5-1 stripped

What moved

  • Trulieve Cannabis (TRLV) received reaffirmed 'Buy' ratings from Cantor Fitzgerald, even as its stock price and chart were noted, following a reported pause in cannabis rescheduling by the DEA. This suggests that some analysts maintain a positive outlook despite regulatory delays, which can influence investor sentiment for the company. [TradingView] [The Globe and Mail] [Investing.com Nigeria]
  • Aurora Cannabis Inc. (ACB) expanded its production capacity, a development that can be significant for its market position and ability to meet demand in an evolving market. Its stock price, news, quote, and history were also tracked. [Yahoo! Finance Canada] [kalkinemedia.com]
  • Decibel Cannabis Company Inc. (DB) saw its stock jump by 3.05%, indicating positive investor attention for the company during the week. [kalkine.ca]
  • Glass House Brands experienced a 17.00% slide in its stock, while Organigram Global Stock also slid, and Curaleaf Holdings stock fell 4.94%. These declines suggest broader selling pressure and cautious investor sentiment within parts of the cannabis sector. [kalkine.ca] [kalkine.ca] [kalkine.ca]
  • A passive holder reported sole voting power in IM Cannabis (IMCC) with a 9.99% stake, which can be a notable development for corporate governance and potential future strategic directions of the company. [Stock Titan]

The why behind the week

  • A reported pause in cannabis rescheduling efforts by the DEA appears to be a significant factor influencing the sector this week. This delay means that the potential benefits of federal reclassification, such as easier access to banking services or reduced tax burdens, remain on hold, which can create uncertainty and impact investor expectations for companies like Trulieve and the broader market. [Seeking Alpha] [Simply Wall Street] [Yahoo Finance] [Investing.com Nigeria]
  • Despite the regulatory pause, some companies like Aurora Cannabis are continuing to expand production capacity. This suggests a strategic focus on long-term growth and market positioning, regardless of immediate federal policy changes, which can be a key driver for individual company performance. [kalkinemedia.com]
  • The varied stock movements, with some companies gaining and others experiencing declines, indicate that the cannabis market is reacting to both macro-level regulatory news and company-specific developments. Investor caution, as noted for Organigram and Glass House Brands, suggests that the overall market environment remains sensitive to both positive and negative catalysts. [kalkine.ca] [kalkine.ca] [kalkine.ca] [kalkine.ca]

📄 Filings that matter (8-Ks, straight from EDGAR)

  • $AFCG — entered a material agreement; took on a new debt obligation [SEC filing] 2026-09-29

The macro backdrop

10-yr Treasury 5.29%Expected inflation 2.4%VIX 15.6High-yield spread 3.24%Yield curve (10y–2y) 0.46%Chance of a 10%+ market fall in 3 months 20% (normal 14%)
How to read it
  • Credit Spread: tight — credit markets are relaxed, no stress being priced
  • Yield Curve: flat — the recession-warning zone; a rapid steepening from here has often preceded the actual downturn
  • Vix: calm — the market is complacent, which cuts both ways (little cushion if news turns)

Every theme swims in this tide — judge the week’s moves against it.

📅 On the calendar — and why it matters here

  • Fri Oct 2 — Jobs report (payrolls + unemployment). sets the growth-vs-recession narrative — a weak number lifts recession odds (hits cyclicals, consumer, financials); a strong one can paradoxically pressure rates. Watch for a surprise vs expectations — that gap, not the number itself, is what moves markets.
  • Fri Oct 2 — FOMC (Fed rate decision / minutes). the single biggest scheduled market mover — a rate surprise in either direction repriced everything, hardest on rate-sensitive names (growth, REITs, utilities, homebuilders). Watch for a surprise vs expectations — that gap, not the number itself, is what moves markets.
  • Wed Oct 14 — CPI (inflation). a hot print pushes rate-cut odds out (pressuring long-duration assets); a soft print does the reverse — one of the highest-impact releases. Watch for a surprise vs expectations — that gap, not the number itself, is what moves markets.
  • Thu Oct 15 — Retail sales. the consumer's pulse — matters most to consumer/retail names. Watch for a surprise vs expectations — that gap, not the number itself, is what moves markets.
  • Thu Oct 15 — PPI (wholesale inflation). wholesale inflation — an early tell on where CPI heads next. Watch for a surprise vs expectations — that gap, not the number itself, is what moves markets.

What to watch next

  • The 10-year Treasury yield at 5.29% indicates a higher cost of capital. For cannabis companies, which may already face challenges in securing traditional financing due to federal regulations, higher interest rates can increase borrowing costs and impact expansion plans or profitability. [macro data]
  • The VIX at 15.58 suggests moderate market volatility. While not extremely high, this level indicates that investors are experiencing some degree of uncertainty, which can lead to cautious sentiment and potentially larger price swings for individual cannabis stocks. [macro data]
  • The high-yield credit spread of 3.24% indicates the additional return investors demand for holding riskier corporate debt compared to safer government bonds. For cannabis companies, which are often considered higher risk, this spread can reflect the cost and availability of non-investment-grade financing, impacting their ability to raise capital. [macro data]
  • The Shiller CAPE ratio at 41.07 suggests that the broader market is trading at a historically high valuation. While not directly tied to cannabis, a high CAPE can imply that investors are paying a premium for earnings, and any significant market correction could have ripple effects on all sectors, including cannabis. [macro data]
  • The median price-to-model-value across 12 cannabis stocks at 1.15x indicates that, on average, these stocks are trading above their calculated intrinsic value. This suggests that the market may be pricing in future growth or positive developments, and any failure to meet those expectations could lead to revaluations. [SAVNG data]

This week’s headlines (sources)

Every claim above cites its source — headlines link to the original outlet; [SAVNG data] marks our own EDGAR-computed figures. Where our sources don’t explain a move, we say so rather than guess. All weekly roundups →

All Cannabis roundups: 2026-W41 · 2026-W39 · 2026-W38 · 2026-W37 · 2026-W36 · every scope →

SAVNG is an educational research publication, not a Registered Investment Adviser. Everything here is general-circulation information produced by an automated pipeline — the same for every reader — and is not personalized investment advice, an offer, or a recommendation to buy or sell any security. Any performance figure is hypothetical; past performance does not predict future results. Details.

Get next week's roundup automatically

Get these in any reader — no email, no account. Paste a link into Feedly, Inoreader, NetNewsWire, or your browser.